Europe AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component (Software & Platform, and Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision), By End Use, By Application, By Country and Growth Forecast, 2025 - 2032
Published Date : 05-Nov-2025 |
Pages: 179 |
Report Format: PDF + Excel |
COVID-19 Impact on the Europe AI In Drug Repurposing Market
Market Overview
The Europe AI In Drug Repurposing Market would witness market growth of 19.3% CAGR during the forecast period (2025-2032).
The Germany market dominated the Europe AI In Drug Repurposing Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $269.5 million by 2032. The UK market is exhibiting a CAGR of 18.3% during (2025 - 2032). Additionally, The France market would experience a CAGR of 20.1% during (2025 - 2032). The Germany and UK led the Europe AI In Drug Repurposing Market by Country with a market share of 25% and 20.7% in 2024. The Italy market is expected to witness a CAGR of 20.2% during throughout the forecast period.
Europe's strong history in life sciences, biomedical research, and strict rules has made it a good place for artificial intelligence to be used in drug repurposing. The field started with academic and translational research centers, but it has grown as computing power and access to biomedical datasets have improved, allowing AI to make repurposing efforts bigger. The market is moving from separate projects to an integrated ecosystem that values data sharing, openness, and precision-driven innovation. This is happening thanks to pan-European initiatives, open data platforms, and regulatory engagement.
Federated learning is being used more and more to protect privacy under GDPR. EU-funded consortia are also helping public and private organizations work together more. There is also a growing focus on making models easier to understand and making sure they follow the rules. Top companies put explainability, interoperability, and compliance first when they spend money on federated data networks and AI platforms that can grow and change. Competition is still changing, and players who know about regulations, can work together, and have proven results in translation have the upper hand. So, the AI market for drug repurposing in Europe is becoming a coordinated and trusted system that balances new ideas with strict rules and ethics.
Component Outlook
Based on Component, the market is segmented into Software & Platform, and Services. The Software & Platform market segment dominated the Germany AI In Drug Repurposing Market by Component is expected to grow at a CAGR of 17.5 % during the forecast period thereby continuing its dominance until 2032. Also, The Services market is anticipated to grow as a CAGR of 18.5 % during the forecast period during (2025 - 2032).
Application Outlook
Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Rare & Orphan Diseases, Cardiology, and Other Application. Among various UK AI In Drug Repurposing Market by Application; The Oncology market achieved a market size of USD $21 Million in 2024 and is expected to grow at a CAGR of 16.8 % during the forecast period. The Cardiology market is predicted to experience a CAGR of 19.4% throughout the forecast period from (2025 - 2032).
Free Valuable Insights: The Global AI In Drug Repurposing Market will Hit USD 4.11 Billion by 2032, at a CAGR of 19.7%
Country Outlook
Germany is a top place for AI-driven drug repurposing because it has a strong research and development ecosystem, a well-established pharmaceutical industry, and forward-thinking digital health policies. Strong collaboration between academia and industry, a lot of public funding, and strict regulatory oversight that makes sure AI models meet high validation standards are all good things for the country. Some important trends are the use of AI to look at genomics and clinical datasets, the rise of federated learning, and a growing interest in rare disease and precision medicine applications. Bayer and Merck KGaA are two of the biggest companies in the market, along with new startups. The market is competitive but open. Germany's well-developed infrastructure and strict rules make it the best place in Europe to advance AI in drug repurposing.
List of Key Companies Profiled
- Ginkgo Bioworks Holdings, Inc.
- IBM Corporation
- Atomwise, Inc.
- Cyclica, Inc.
- Genesis Healthcare Co.
- Verge, Inc.
- Novartis AG
- Schrödinger, Inc
- Recursion Pharmaceuticals, Inc.
- The Cradle Company
Europe AI In Drug Repurposing Market Report Segmentation
By Component
- Software & Platform
- Services
By Technology
- Machine Learning/Deep Learning
- Natural Language Processing (NLP)
- Knowledge Graphs & Network-Based AI
- Generative AI & Large Language Models (LLMs)
- Computer Vision
By End Use
- Pharmaceutical & BioTechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Other End Use
By Application
- Oncology
- Neurology
- Infectious Diseases
- Rare & Orphan Diseases
- Cardiology
- Other Application
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI In Drug Repurposing Market, by Component
1.4.2 Europe AI In Drug Repurposing Market, by Technology
1.4.3 Europe AI In Drug Repurposing Market, by End Use
1.4.4 Europe AI In Drug Repurposing Market, by Application
1.4.5 Europe AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – Europe AI In Drug Repurposing Market
Chapter 5. State of Competition - Europe AI in Drug Repurposing market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Europe AI In Drug Repurposing Market by Component
10.1 Europe Software & Platform Market by Country
10.2 Europe Services Market by Country
Chapter 11. Europe AI In Drug Repurposing Market by Technology
11.1 Europe Machine Learning/Deep Learning Market by Country
11.2 Europe Natural Language Processing (NLP) Market by Country
11.3 Europe Knowledge Graphs & Network-Based AI Market by Country
11.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
11.5 Europe Computer Vision Market by Country
Chapter 12. Europe AI In Drug Repurposing Market by End Use
12.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
12.2 Europe Contract Research Organizations (CROs) Market by Country
12.3 Europe Academic & Research Institutes Market by Country
12.4 Europe Other End Use Market by Country
Chapter 13. Europe AI In Drug Repurposing Market by Application
13.1 Europe Oncology Market by Country
13.2 Europe Neurology Market by Country
13.3 Europe Infectious Diseases Market by Country
13.4 Europe Rare & Orphan Diseases Market by Country
13.5 Europe Cardiology Market by Country
13.6 Europe Other Application Market by Country
Chapter 14. Europe AI In Drug Repurposing Market by Country
14.1 Germany AI In Drug Repurposing Market
14.1.1 Germany AI In Drug Repurposing Market by Component
14.1.2 Germany AI In Drug Repurposing Market by Technology
14.1.3 Germany AI In Drug Repurposing Market by End Use
14.1.4 Germany AI In Drug Repurposing Market by Application
14.2 UK AI In Drug Repurposing Market
14.2.1 UK AI In Drug Repurposing Market by Component
14.2.2 UK AI In Drug Repurposing Market by Technology
14.2.3 UK AI In Drug Repurposing Market by End Use
14.2.4 UK AI In Drug Repurposing Market by Application
14.3 France AI In Drug Repurposing Market
14.3.1 France AI In Drug Repurposing Market by Component
14.3.2 France AI In Drug Repurposing Market by Technology
14.3.3 France AI In Drug Repurposing Market by End Use
14.3.4 France AI In Drug Repurposing Market by Application
14.4 Russia AI In Drug Repurposing Market
14.4.1 Russia AI In Drug Repurposing Market by Component
14.4.2 Russia AI In Drug Repurposing Market by Technology
14.4.3 Russia AI In Drug Repurposing Market by End Use
14.4.4 Russia AI In Drug Repurposing Market by Application
14.5 Spain AI In Drug Repurposing Market
14.5.1 Spain AI In Drug Repurposing Market by Component
14.5.2 Spain AI In Drug Repurposing Market by Technology
14.5.3 Spain AI In Drug Repurposing Market by End Use
14.5.4 Spain AI In Drug Repurposing Market by Application
14.6 Italy AI In Drug Repurposing Market
14.6.1 Italy AI In Drug Repurposing Market by Component
14.6.2 Italy AI In Drug Repurposing Market by Technology
14.6.3 Italy AI In Drug Repurposing Market by End Use
14.6.4 Italy AI In Drug Repurposing Market by Application
14.7 Rest of Europe AI In Drug Repurposing Market
14.7.1 Rest of Europe AI In Drug Repurposing Market by Component
14.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
14.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
14.7.4 Rest of Europe AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI In Drug Repurposing Market, by Component
1.4.2 Europe AI In Drug Repurposing Market, by Technology
1.4.3 Europe AI In Drug Repurposing Market, by End Use
1.4.4 Europe AI In Drug Repurposing Market, by Application
1.4.5 Europe AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – Europe AI In Drug Repurposing Market
Chapter 5. State of Competition - Europe AI in Drug Repurposing market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Europe AI In Drug Repurposing Market by Component
10.1 Europe Software & Platform Market by Country
10.2 Europe Services Market by Country
Chapter 11. Europe AI In Drug Repurposing Market by Technology
11.1 Europe Machine Learning/Deep Learning Market by Country
11.2 Europe Natural Language Processing (NLP) Market by Country
11.3 Europe Knowledge Graphs & Network-Based AI Market by Country
11.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
11.5 Europe Computer Vision Market by Country
Chapter 12. Europe AI In Drug Repurposing Market by End Use
12.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
12.2 Europe Contract Research Organizations (CROs) Market by Country
12.3 Europe Academic & Research Institutes Market by Country
12.4 Europe Other End Use Market by Country
Chapter 13. Europe AI In Drug Repurposing Market by Application
13.1 Europe Oncology Market by Country
13.2 Europe Neurology Market by Country
13.3 Europe Infectious Diseases Market by Country
13.4 Europe Rare & Orphan Diseases Market by Country
13.5 Europe Cardiology Market by Country
13.6 Europe Other Application Market by Country
Chapter 14. Europe AI In Drug Repurposing Market by Country
14.1 Germany AI In Drug Repurposing Market
14.1.1 Germany AI In Drug Repurposing Market by Component
14.1.2 Germany AI In Drug Repurposing Market by Technology
14.1.3 Germany AI In Drug Repurposing Market by End Use
14.1.4 Germany AI In Drug Repurposing Market by Application
14.2 UK AI In Drug Repurposing Market
14.2.1 UK AI In Drug Repurposing Market by Component
14.2.2 UK AI In Drug Repurposing Market by Technology
14.2.3 UK AI In Drug Repurposing Market by End Use
14.2.4 UK AI In Drug Repurposing Market by Application
14.3 France AI In Drug Repurposing Market
14.3.1 France AI In Drug Repurposing Market by Component
14.3.2 France AI In Drug Repurposing Market by Technology
14.3.3 France AI In Drug Repurposing Market by End Use
14.3.4 France AI In Drug Repurposing Market by Application
14.4 Russia AI In Drug Repurposing Market
14.4.1 Russia AI In Drug Repurposing Market by Component
14.4.2 Russia AI In Drug Repurposing Market by Technology
14.4.3 Russia AI In Drug Repurposing Market by End Use
14.4.4 Russia AI In Drug Repurposing Market by Application
14.5 Spain AI In Drug Repurposing Market
14.5.1 Spain AI In Drug Repurposing Market by Component
14.5.2 Spain AI In Drug Repurposing Market by Technology
14.5.3 Spain AI In Drug Repurposing Market by End Use
14.5.4 Spain AI In Drug Repurposing Market by Application
14.6 Italy AI In Drug Repurposing Market
14.6.1 Italy AI In Drug Repurposing Market by Component
14.6.2 Italy AI In Drug Repurposing Market by Technology
14.6.3 Italy AI In Drug Repurposing Market by End Use
14.6.4 Italy AI In Drug Repurposing Market by Application
14.7 Rest of Europe AI In Drug Repurposing Market
14.7.1 Rest of Europe AI In Drug Repurposing Market by Component
14.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
14.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
14.7.4 Rest of Europe AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
List of Tables
TABLE 1 Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 2 Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 Europe Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 7 Europe Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 8 Europe Services Market by Country, 2021 - 2024, USD Million
TABLE 9 Europe Services Market by Country, 2025 - 2032, USD Million
TABLE 10 Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 Europe Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 13 Europe Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 14 Europe Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 15 Europe Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 16 Europe Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 17 Europe Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 18 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 19 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 20 Europe Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 21 Europe Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 22 Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 25 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 26 Europe Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 27 Europe Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 28 Europe Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 29 Europe Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 30 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 31 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 32 Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 Europe Oncology Market by Country, 2021 - 2024, USD Million
TABLE 35 Europe Oncology Market by Country, 2025 - 2032, USD Million
TABLE 36 Europe Neurology Market by Country, 2021 - 2024, USD Million
TABLE 37 Europe Neurology Market by Country, 2025 - 2032, USD Million
TABLE 38 Europe Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 39 Europe Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 40 Europe Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 41 Europe Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 42 Europe Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 43 Europe Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 44 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 45 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 46 Europe AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 47 Europe AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 48 Germany AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 Germany AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 Germany AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 Germany AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 Germany AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 53 Germany AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 54 Germany AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 55 Germany AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 56 Germany AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 57 Germany AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 58 UK AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 59 UK AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 60 UK AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 61 UK AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 62 UK AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 63 UK AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 64 UK AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 65 UK AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 66 UK AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 67 UK AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 68 France AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 69 France AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 70 France AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 71 France AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 72 France AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 73 France AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 74 France AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 75 France AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 76 France AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 77 France AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 78 Russia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 79 Russia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 80 Russia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 81 Russia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 82 Russia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 83 Russia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 84 Russia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 85 Russia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 86 Russia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 87 Russia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 88 Spain AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 89 Spain AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 90 Spain AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 91 Spain AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 92 Spain AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 93 Spain AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 94 Spain AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 95 Spain AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 96 Spain AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 97 Spain AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 98 Italy AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 99 Italy AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 100 Italy AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 101 Italy AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 102 Italy AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 103 Italy AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 104 Italy AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 105 Italy AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 106 Italy AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 107 Italy AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 108 Rest of Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 109 Rest of Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 110 Rest of Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 111 Rest of Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 112 Rest of Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 113 Rest of Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 114 Rest of Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 115 Rest of Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 116 Rest of Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 117 Rest of Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 118 Key Information – GINKGO BIOWORKS HOLDINGS, INC.
TABLE 119 Key Information – IBM Corporation
TABLE 120 Key Information – Atomwise, Inc.
TABLE 121 Key Information – Cyclica, Inc.
TABLE 122 Key Information – Genesis Healthcare Co.
TABLE 123 Key Information – Verge, Inc.
TABLE 124 Key Information – Novartis AG
TABLE 125 Key Information – Schrödinger, Inc
TABLE 126 Key Information – Recursion Pharmaceuticals, Inc.
TABLE 127 Key Information – The Cradle Company
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Europe AI In Drug Repurposing Market
FIG 4 Porter’s Five Forces Analysis – AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle – AI In Drug Repurposing Market
FIG 7 Market Consolidation – AI In Drug Repurposing Market
FIG 8 Key Customer Criteria – AI In Drug Repurposing Market
FIG 9 Europe AI In Drug Repurposing Market share by Component, 2024
FIG 10 Europe AI In Drug Repurposing Market share by Component, 2032
FIG 11 Europe AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 Europe AI In Drug Repurposing Market share by Technology, 2024
FIG 13 Europe AI In Drug Repurposing Market share by Technology, 2032
FIG 14 Europe AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 Europe AI In Drug Repurposing Market share by End Use, 2024
FIG 16 Europe AI In Drug Repurposing Market share by End Use, 2032
FIG 17 Europe AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 Europe AI In Drug Repurposing Market share by Application, 2024
FIG 19 Europe AI In Drug Repurposing Market share by Application, 2032
FIG 20 Europe AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 Europe AI In Drug Repurposing Market share by Country, 2024
FIG 22 Europe AI In Drug Repurposing Market share by Country, 2032
FIG 23 Europe AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 24 Swot Analysis: Ginkgo Bioworks
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: Novartis AG
TABLE 2 Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 Europe Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 7 Europe Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 8 Europe Services Market by Country, 2021 - 2024, USD Million
TABLE 9 Europe Services Market by Country, 2025 - 2032, USD Million
TABLE 10 Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 Europe Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 13 Europe Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 14 Europe Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 15 Europe Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 16 Europe Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 17 Europe Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 18 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 19 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 20 Europe Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 21 Europe Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 22 Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 25 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 26 Europe Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 27 Europe Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 28 Europe Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 29 Europe Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 30 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 31 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 32 Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 Europe Oncology Market by Country, 2021 - 2024, USD Million
TABLE 35 Europe Oncology Market by Country, 2025 - 2032, USD Million
TABLE 36 Europe Neurology Market by Country, 2021 - 2024, USD Million
TABLE 37 Europe Neurology Market by Country, 2025 - 2032, USD Million
TABLE 38 Europe Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 39 Europe Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 40 Europe Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 41 Europe Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 42 Europe Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 43 Europe Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 44 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 45 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 46 Europe AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 47 Europe AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 48 Germany AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 Germany AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 Germany AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 Germany AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 Germany AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 53 Germany AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 54 Germany AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 55 Germany AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 56 Germany AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 57 Germany AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 58 UK AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 59 UK AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 60 UK AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 61 UK AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 62 UK AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 63 UK AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 64 UK AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 65 UK AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 66 UK AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 67 UK AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 68 France AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 69 France AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 70 France AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 71 France AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 72 France AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 73 France AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 74 France AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 75 France AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 76 France AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 77 France AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 78 Russia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 79 Russia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 80 Russia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 81 Russia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 82 Russia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 83 Russia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 84 Russia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 85 Russia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 86 Russia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 87 Russia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 88 Spain AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 89 Spain AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 90 Spain AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 91 Spain AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 92 Spain AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 93 Spain AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 94 Spain AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 95 Spain AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 96 Spain AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 97 Spain AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 98 Italy AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 99 Italy AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 100 Italy AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 101 Italy AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 102 Italy AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 103 Italy AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 104 Italy AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 105 Italy AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 106 Italy AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 107 Italy AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 108 Rest of Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 109 Rest of Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 110 Rest of Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 111 Rest of Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 112 Rest of Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 113 Rest of Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 114 Rest of Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 115 Rest of Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 116 Rest of Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 117 Rest of Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 118 Key Information – GINKGO BIOWORKS HOLDINGS, INC.
TABLE 119 Key Information – IBM Corporation
TABLE 120 Key Information – Atomwise, Inc.
TABLE 121 Key Information – Cyclica, Inc.
TABLE 122 Key Information – Genesis Healthcare Co.
TABLE 123 Key Information – Verge, Inc.
TABLE 124 Key Information – Novartis AG
TABLE 125 Key Information – Schrödinger, Inc
TABLE 126 Key Information – Recursion Pharmaceuticals, Inc.
TABLE 127 Key Information – The Cradle Company
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Europe AI In Drug Repurposing Market
FIG 4 Porter’s Five Forces Analysis – AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle – AI In Drug Repurposing Market
FIG 7 Market Consolidation – AI In Drug Repurposing Market
FIG 8 Key Customer Criteria – AI In Drug Repurposing Market
FIG 9 Europe AI In Drug Repurposing Market share by Component, 2024
FIG 10 Europe AI In Drug Repurposing Market share by Component, 2032
FIG 11 Europe AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 Europe AI In Drug Repurposing Market share by Technology, 2024
FIG 13 Europe AI In Drug Repurposing Market share by Technology, 2032
FIG 14 Europe AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 Europe AI In Drug Repurposing Market share by End Use, 2024
FIG 16 Europe AI In Drug Repurposing Market share by End Use, 2032
FIG 17 Europe AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 Europe AI In Drug Repurposing Market share by Application, 2024
FIG 19 Europe AI In Drug Repurposing Market share by Application, 2032
FIG 20 Europe AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 Europe AI In Drug Repurposing Market share by Country, 2024
FIG 22 Europe AI In Drug Repurposing Market share by Country, 2032
FIG 23 Europe AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 24 Swot Analysis: Ginkgo Bioworks
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: Novartis AG